I worry that this inappropriately treats biosimilars like generic drugs and will disincentivize manufacturers from entering the biosimilars marketplace.
Frank Pallone: “I worry that this inappropriately treats biosimilars like generic drugs and will disincentivize manufacturers from…”
Editor's note · Context
Pallone expresses concern over CMS's payment policy for biosimilars affecting market entry.
Share
More from Frank Pallone
For years, I’ve fought for federal funding to make the Carteret ferry a reality because projects like this make a real difference in people’s lives. This $9.6 million investment helps to put another vessel on the water and takes cars off…
As the top Congressional leaders with oversight of the Federal Emergency Management Agency (FEMA), it is within your jurisdiction to ensure our nation’s disaster relief efforts are “fast, fair, and free from political bias,” as Chairman…
I will continue fighting for an immigration system that upholds due process, keeps families together and treats everyone with dignity while providing a pathway to citizenship.
If Delaney Hall cannot be operated in compliance with federal law and the Constitution, GEO Group should not continue to profit from taxpayer dollars and Delaney Hall should be closed.





